These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26093888)

  • 1. Big Data and Health Economics: Strengths, Weaknesses, Opportunities and Threats.
    Collins B
    Pharmacoeconomics; 2016 Feb; 34(2):101-6. PubMed ID: 26093888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming Healthcare Delivery: Integrating Dynamic Simulation Modelling and Big Data in Health Economics and Outcomes Research.
    Marshall DA; Burgos-Liz L; Pasupathy KS; Padula WV; IJzerman MJ; Wong PK; Higashi MK; Engbers J; Wiebe S; Crown W; Osgood ND
    Pharmacoeconomics; 2016 Feb; 34(2):115-26. PubMed ID: 26497003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Big Data and Its Role in Health Economics and Outcomes Research: A Collection of Perspectives on Data Sources, Measurement, and Analysis.
    Onukwugha E
    Pharmacoeconomics; 2016 Feb; 34(2):91-3. PubMed ID: 26809339
    [No Abstract]   [Full Text] [Related]  

  • 4. Realising the Value of Linked Data to Health Economic Analyses of Cancer Care: A Case Study of Cancer 2015.
    Lorgelly PK; Doble B; Knott RJ;
    Pharmacoeconomics; 2016 Feb; 34(2):139-54. PubMed ID: 26547307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usability of databases in health economics].
    Brüggenjürgen B; Willich SN
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Jan; 49(1):11-8. PubMed ID: 16362135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Strengths, Weaknesses, Opportunities, and Threats as a Tool for Translating Evidence into Individualized Medical Strategies (I-SWOT).
    von Kodolitsch Y; Bernhardt AM; Robinson PN; Kölbel T; Reichenspurner H; Debus S; Detter C
    Aorta (Stamford); 2015 Jun; 3(3):98-107. PubMed ID: 27069939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using epidemiological surveillance systems and routine data sets to study place of care and place of death: strengths and weaknesses.
    O'Sullivan EM
    Palliat Med; 2011 Jan; 25(1):94-6. PubMed ID: 21245081
    [No Abstract]   [Full Text] [Related]  

  • 8. Research Techniques Made Simple: An Introduction to Use and Analysis of Big Data in Dermatology.
    Wehner MR; Levandoski KA; Kulldorff M; Asgari MM
    J Invest Dermatol; 2017 Aug; 137(8):e153-e158. PubMed ID: 28735616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world evidence in pain research: a review of data sources.
    Bellows BK; Kuo KL; Biltaji E; Singhal M; Jiao T; Cheng Y; McAdam-Marx C
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):294-304. PubMed ID: 25136897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
    O'Donnell JC
    Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data, data everywhere: the challenges of personalised medicine.
    Armstrong S
    BMJ; 2017 Oct; 359():j4546. PubMed ID: 29021195
    [No Abstract]   [Full Text] [Related]  

  • 12. Real-world data in the United Kingdom: opportunities and challenges.
    McDonald L; Lambrelli D; Wasiak R; Ramagopalan SV
    BMC Med; 2016 Jun; 14(1):97. PubMed ID: 27342341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using population-based routine data for evidence-based health policy decisions: lessons from three examples of setting and evaluating national health policy in Australia, the UK and the USA.
    Morrato EH; Elias M; Gericke CA
    J Public Health (Oxf); 2007 Dec; 29(4):463-71. PubMed ID: 17942850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities.
    Beckmann JS; Lew D
    Genome Med; 2016 Dec; 8(1):134. PubMed ID: 27993174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital Pharmacovigilance and Disease Surveillance: Combining Traditional and Big-Data Systems for Better Public Health.
    Salathé M
    J Infect Dis; 2016 Dec; 214(suppl_4):S399-S403. PubMed ID: 28830106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Big Data in radiation therapy: challenges and opportunities.
    Lustberg T; van Soest J; Jochems A; Deist T; van Wijk Y; Walsh S; Lambin P; Dekker A
    Br J Radiol; 2017 Jan; 90(1069):20160689. PubMed ID: 27781485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The loss of the NHS EED and DARE databases and the effect on evidence synthesis and evaluation.
    Briscoe S; Cooper C; Glanville J; Lefebvre C
    Res Synth Methods; 2017 Sep; 8(3):256-257. PubMed ID: 28268247
    [No Abstract]   [Full Text] [Related]  

  • 18. Using 'big data' to validate claims made in the pharmaceutical approval process.
    Wasser T; Haynes K; Barron J; Cziraky M
    J Med Econ; 2015; 18(12):1013-9. PubMed ID: 26548546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive IT-systems for big data analysis in medicine.
    Isakova J
    Int J Risk Saf Med; 2015; 27 Suppl 1():S108-9. PubMed ID: 26639685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II.
    Cox E; Martin BC; Van Staa T; Garbe E; Siebert U; Johnson ML
    Value Health; 2009; 12(8):1053-61. PubMed ID: 19744292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.